Ontology highlight
ABSTRACT: Objective
Individuals with the neurofibromatosis type 2 (NF2) cancer predisposition syndrome develop spinal cord glial tumors (ependymomas) that likely originate from neural progenitor cells. Whereas many spinal ependymomas exhibit indolent behavior, the only treatment option for clinically symptomatic tumors is surgery. In this regard, medical therapies are unfortunately lacking due to an incomplete understanding of the critical growth control pathways that govern the function of spinal cord (SC) neural progenitor cells (NPCs).Methods
To identify potential therapeutic targets for these tumors, we leveraged primary mouse Nf2-deficient spinal cord neural progenitor cells.Results
We demonstrate that the Nf2 protein, merlin, negatively regulates spinal neural progenito
SUBMITTER: Garcia C
PROVIDER: S-EPMC4016309 | biostudies-literature | 2014
REPOSITORIES: biostudies-literature